Annelieke R. Müller

Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM

Annelieke R. Müller, Michiel A. J. Luijten, Lotte Haverman et al. · BMC Medicine · 2023 · 18 citations · Full text

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials

Annelieke R. Müller, Janneke Zinkstok, Nanda Rommelse et al. · Orphanet Journal of Rare Diseases · 2021 · 11 citations · Full text

Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials

Annelieke R. Müller, Bibiche den Hollander, Peter M. van de Ven et al. · BMC Psychiatry · 2024 · 10 citations · Full text